Search results for Sun Pharma

Indian drugmakers look beyond generics as Sun Pharma buys Organon

Sun Pharma Q4 PAT up 26% to Rs 2,714 crore; announces final dividend — check amount here

The country's largest drugmaker posted a profit after tax (PAT) of Rs 2,714 crore in Q4 FY26 compared with Rs 2,149.9 crore in the corresponding quarter last year.

India’s Sun Pharma to acquire US-listed Organon in $11.8 billion deal

Sun Pharma Q4 net profit up 26% at ₹2,714 crore

Sales up 13.6% at ₹14,559 crore in the quarter under review

Sun Pharma to acquire US-based Organon in $11.75bn deal

Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India's largest overse...

Sun Pharma buys US-based Organon for $12 billion in biggest-ever overseas pharma deal

India's largest pharma company, Sun Pharma, has made its biggest overseas acquisition, buying Organon & Co for $11.8 billion. This deal significantly expands Sun Pharma's globa...

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid drag

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lost Revlimid sales and pricing challenges....

Sun Pharma to acquire Organon for $11.75B

Sun Pharmaceutical Industries and Organon & Co. in Jersey City announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding...

Sun Pharma puts in place team to integrate Organon global operations

Integration committee to be operational in less than a month, ready to roll out once all approvals come in

<![CDATA[Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon ]]>

Pharma stock jumps 9% after signing $11.75 Bil deal to acquire US-based firm

Synopsis:- Sun Pharmaceutical Industries has signed a definitive agreement to acquire Organon & Co. for $14 per share in an all-cash deal worth $11.75 billion in enterprise val...

Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0.63 per cent to Rs 1,332.

Sun Pharma inks ‘transformatory’ agreement to buy US-based Organon for $11.75 billion

On completion of the deal, the combined entity will have $12.4 billion in revenue, placing Sun among the top 25 global pharma firms

Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscape

Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The deal leverages Organon's strengths in wom...

Zydus and Lupin Join Alembic in 180-Day Sprint for $10.5 Billion Dapagliflozin Market

Synopsis: Zydus, Lupin, and Biocon join Alembic in a high-stakes US launch of generic Farxiga, sharing 180-day exclusivity for a blockbuster diabetes drug with $10.5 billion in ann...

What does Sun Pharma gain from its $12-billion Organon bid?

Proposed deal adds women’s health portfolio and US front-end operations

Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase

Sun Pharma and Organon said the combined company would rank among the top three in global women’s health, become the world’s seventh‑largest biosimilar player, and operate in 150 c...

Sun Pharma-Organon deal: Outlook is mixed

Acquisition doubles footprint but growth challenges are considerable

Aiming for the Sun: How the $11.75 billion Organon buy is cementing Dilip Shanghvi’s legacy

India’s Biggest Pharma Deal: Everything You Need To Know | What's Hot

Markets kick off the week on a strong note as What’s Hot with Sakshi Batra tracks the biggest buzz on D-Street. From earnings-driven moves in key stocks to sectoral churn, volatili...

Pharma Stock in Focus After Receiving USFDA Approval for Benzonatate Capsules

Synopsis: The shares of this company rose 8.9 percent following a press release announcing USFDA approval for its Benzonatate Capsules, boosting investor confidence. The share of t...

<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>

20% Upper Circuit: Pharma Stock Skyrockets After Announcing Strong Q4 Earnings

Synopsis: The share of this pharma company hit a 20 percent upper circuit after strong Q4 FY26 earnings driven by anesthetic demand, robust margins, and export-led growth momentum....